Literature DB >> 13428853

Apparent inhibition of liver insulinase activity by serum and serum fractions containing insulin-binding antibody.

R S YALOW, S A BERSON.   

Abstract

Entities:  

Keywords:  ANTIBODIES; ENZYMES; INSULIN/in blood; LIVER/metabolism

Mesh:

Substances:

Year:  1957        PMID: 13428853      PMCID: PMC441732          DOI: 10.1172/JCI103465

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  The destruction of I131-labeled insulin by rat liver extracts.

Authors:  I A MIRSKY; G PERISUTTI; F J DIXON
Journal:  J Biol Chem       Date:  1955-05       Impact factor: 5.157

2.  Localization of an insulin-neutralizing factor by zone electrophoresis in a serum of an insulin-resistant patient.

Authors:  A H SEHON; M KAYE; E McGARRY; B ROSE
Journal:  J Lab Clin Med       Date:  1955-05

3.  Distribution of blocking antibody in human serum proteins fractionated by electrophoresis-convection.

Authors:  M LOVELESS; J R CANN
Journal:  J Immunol       Date:  1955-05       Impact factor: 5.422

4.  Inhibition of insulin action by serum gamma globulin.

Authors:  A R COLWELL; R W WEIGER
Journal:  J Lab Clin Med       Date:  1956-06

5.  Ethanol fractionation of plasma and electrophoretic identification of insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

6.  In vivo and in vitro metabolism of insulin-I 131 and glucagon-I 131 in normal and cortisone-treated rabbits.

Authors:  S A BERSON; R S YALOW; B W VOLK
Journal:  J Lab Clin Med       Date:  1957-03

7.  Insulin distribution and degradation.

Authors:  R H WILLIAMS
Journal:  Metabolism       Date:  1956-03       Impact factor: 8.694

8.  Insulin and adrenocorticotropin labelled with radio-iodine.

Authors:  J W FERREBEE; B B JOHNSON; J C MITHOEFER; J W GARDELLA
Journal:  Endocrinology       Date:  1951-03       Impact factor: 4.736

9.  Insulin-neutralizing activity of gamma-globulins derived from the serum of an insulin-resistant patient.

Authors:  V DE FILIPPIS; A IANNACCONE
Journal:  Lancet       Date:  1952-06-14       Impact factor: 79.321

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  9 in total

1.  INSULIN antibodies.

Authors: 
Journal:  Br Med J       Date:  1958-12-13

2.  Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection.

Authors:  E W MOORE; M L MITCHELL; T C CHALMERS
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

3.  Glucagon antibodies and an immunoassay for glucagon.

Authors:  R H UNGER; A M EISENTRAUT; M S McCALL; L L MADISON
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

4.  Carbohydrate metabolism in pregnancy. I. The metabolism of insulin by human placental tissue.

Authors:  N FREINKEL; C J GOODNER
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

5.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

6.  Ethanol fractionation of plasma and electrophoretic identification of insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

7.  The role of nonprecipitating insulin antibodies in diabetes.

Authors:  J H SKOM; D W TALMAGE
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

8.  Experimental Research on Diabetes Mellitus.

Authors:  F G Young
Journal:  Br Med J       Date:  1961-12-02

Review 9.  Insulin antibodies.

Authors:  J M Stowers
Journal:  Postgrad Med J       Date:  1969-01       Impact factor: 2.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.